Nectar Lifesciences Q2 Results
- BSE: 532649
- NSE: NECLIFE
- ISIN: INE023H01027
- Sector: Biotechnology & Drugs
BSE
33.32
-0.68 (-2.00%)
-0.68 (-2.00%)Volume27.31 K
Updated: Mon 25 Nov, 2024 | 15:15:00
NSE
32.95-0.64 (-1.91%)
-0.64 (-1.91%)Volume7.24 L
Updated: Mon 25 Nov, 2024 | 15:15:07
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹428.10 Cr.(19.15%)
- Operating Profit₹27.78 Cr.(14.14%)
- Profit After Tax₹5.60 Cr.(88.57%)
- Operating Margin6.49%(123.58%)
Note: Comparison is on YoY basis
Quarterly - Nectar Lifesciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 428.10 | 394.12 | -% | 397.96 | -% |
| Selling/ General/ Admin Expenses Total | 24.18 | 18.80 | -% | 20.31 | -% |
| Depreciation/ Amortization | 15.55 | 15.33 | -% | 15.31 | -% |
| Other Operating Expenses Total | 64.54 | 60.62 | -% | 63.00 | -% |
| Total Operating Expense | 400.31 | 373.91 | -% | 386.41 | -% |
| Operating Income | 27.78 | 20.21 | -% | 11.55 | -% |
| Net Income Before Taxes | 8.67 | 3.06 | -% | 1.64 | -% |
| Net Income | 5.60 | 1.82 | -% | 1.02 | -% |
| Diluted Normalized EPS | 0.25 | 0.08 | -% | 0.05 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST